Found 15 matching trials
A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy
PHASE1This is an open label, multi-center study to evaluate the safety, tolerabil...
Location
GenesisCare North Shore
THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines
PHASE1This is a phase 1/2 open-label study assessing the safety, reactogenicity, ...
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
PHASE1MNA-3521-011 study is a multi-centre, open-label, first-in-human, phase 1a/...
Location
National University Hospital
IMP3-saRNA Vaccine in Advanced NSCLC
PHASE1This is an open-label, single-arm, non-randomized, single-center, prospecti...
Location
West China Hospital, Sichuan University, Chengdu, Sichuan
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
PHASE1The goal of this clinical trial is to assess the safety and tolerability of...
Location
Stanford University
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
PHASE1This study tests an investigational cancer vaccine called ITI-5000 in peopl...
A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy
EARLY_PHASE1This is an open-label, single-arm, dose-escalation trial to evaluate the sa...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza
PHASE1The purpose of this clinical trial is to learn about the safety and effects...
Location
Arizona Heart Rhythm Center
A Study of MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT)
PHASE1This is an open label Phase 1a/1b study in patients who have advanced solid...
Location
Guys and St Thomas NHS Foundation Trust
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
PHASE2This is a Phase II study in patients with advanced liver cancer (hepatocell...